Frank Rimerman Advisors’s Medtronic MDT Stock Holding History

Frank Rimerman Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24M	Buy	14,365 +1,274	+10%	+$122K	0.08%	199
2025 Q4	$1.26M	Buy	13,091 +766	+6%	+$74.4K	0.08%	195
2025 Q3	$1.17M	Buy	12,325 +2,784	+29%	+$256K	0.08%	207
2025 Q2	$832K	Buy	9,541 +2,247	+31%	+$191K	0.06%	246
2025 Q1	$655K	Buy	7,294 +3,316	+83%	+$297K	0.05%	263
2024 Q4	$318K	Sell	3,978 -11,805	-75%	-$1.02M	0.02%	396
2024 Q3	$1.42M	Sell	15,783 -6,629	-30%	-$558K	0.1%	164
2024 Q2	$1.76M	Buy	22,412 +22,064	+6,340%	+$1.81M	0.12%	130
2024 Q1	$30.3K	Buy	+348	New	+$29.7K	0.01%	139

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frank Rimerman Advisors's MDT Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Medtronic (MDT) stake by 9.7% in Q1 2026, buying an estimated $122K and bringing the position to 14,365 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #199.

Frank Rimerman Advisors first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.76M in Q2 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Frank Rimerman Advisors held 14,365 shares of Medtronic worth $1.24M as of Q1 2026.
Frank Rimerman Advisors bought 1,274 Medtronic shares in Q1 2026, an estimated $122K.
Medtronic made up 0.08% of Frank Rimerman Advisors's portfolio in Q1 2026, its #199 holding.
Frank Rimerman Advisors first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
Frank Rimerman Advisors's Medtronic position peaked at $1.76M in Q2 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.